Viatris Inc. (NASDAQ:VTRS) is one of the 13 extreme value stocks to buy now. Viatris Inc. (NASDAQ:VTRS) is covered by 12 ...

Viatris Inc. (NASDAQ:VTRS) is one of the 10 Best Stocks Under $20 to Buy According to Hedge Funds. On February 27, UBS raised its price target on Viatris Inc. (NASDAQ:VTRS) from $18 to $20 and ...

Is On Investors’ Radar Viatris (VTRS) is drawing attention after a mixed stretch in its share performance, with a negative move over the past month but a positive total return over the past 3 months ...

Viatris Inc. (NASDAQ:VTRS) is included among the 13 Best March Dividend Stocks to Buy. On February 27, UBS raised its price recommendation on Viatris Inc. (NASDAQ:VTRS) to $20 from $18. It maintained ...

The market expects Viatris (VTRS) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended September 2025. This widely-known consensus outlook is ...

Viatris (VTRS) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of ...

Viatris (VTRS) shares recorded modest gains in the premarket on Thursday after the Xanax maker exceeded Street forecasts with its Q3 2025 financials thanks mainly to growth in emerging markets, and ...

Viatris ( (VTRS)) has issued an announcement. On February 26, 2026, Viatris reported robust fourth-quarter 2025 revenues of $3.7 billion and full-year revenues of $14.3 billion, meeting or exceeding ...

Viatris Inc. (NASDAQ:VTRS) is included among the 13 Best March Dividend Stocks to Buy. On February 27, UBS raised its price recommendation on Viatris Inc. (NASDAQ:VTRS) to $20 from $18. It maintained ...